The Mark H. Zangmeister Center — Columbus, Ohio

The Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

The Mark H. Zangmeister Center has participated in 6 clinical trials.

Therapeutic areas: Tumors, Prostate Cancer, HER2-negative Breast Cancer.

Sponsors: Mateon Therapeutics, Achieve Life Sciences, NSABP Foundation Inc.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H. Zangmeister Center?

The Mark H. Zangmeister Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H. Zangmeister Center conducted?

The Mark H. Zangmeister Center has 6 clinical trials on record. Their work covers Tumors, Prostate Cancer, HER2-negative Breast Cancer.

Is The Mark H. Zangmeister Center accredited by Crixeo Health?

Yes — The Mark H. Zangmeister Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Mark H. Zangmeister Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.